Article Versions Notes

Fusco M, Picón CR, Diaz MA, Bayo J, Arriola Benitez PC, Piccioni F, Gómez N, Stinco M, Martínez Martinez J, Minatta JN, et al. 4-Methylumbelliferone Modulates CAIX to Mitigate Hypoxia-Driven Dysregulation and Enhance PD-1 Immunotherapy in Lung Cancer. International Journal of Molecular Sciences. 2025; 26(21):10427. https://doi.org/10.3390/ijms262110427

Fusco, Mariel, Carlos Rafael Picón, Marco Aurelio Diaz, Juan Bayo, Paula Constanza Arriola Benitez, Flavia Piccioni, Noelia Gómez, Mara Stinco, Javier Martínez Martinez, José Nicolás Minatta, and et al. 2025. "4-Methylumbelliferone Modulates CAIX to Mitigate Hypoxia-Driven Dysregulation and Enhance PD-1 Immunotherapy in Lung Cancer" International Journal of Molecular Sciences 26, no. 21: 10427. https://doi.org/10.3390/ijms262110427

Fusco, M., Picón, C. R., Diaz, M. A., Bayo, J., Arriola Benitez, P. C., Piccioni, F., Gómez, N., Stinco, M., Martínez Martinez, J., Minatta, J. N., Amorín, R., Villar, M., Sole, V., Cassol, I., De Marzi, M., Rizzo, M. M., Mercogliano, M. F., & Malvicini, M. (2025). 4-Methylumbelliferone Modulates CAIX to Mitigate Hypoxia-Driven Dysregulation and Enhance PD-1 Immunotherapy in Lung Cancer. International Journal of Molecular Sciences, 26(21), 10427. https://doi.org/10.3390/ijms262110427